HBOT Conversations:
Dr. Paul Harch & Strokes
Dr. Paul G. Harch, M.D. has used hyperbaric oxygen therapy to treat more than 100 different conditions, including stroke, dementia, autism, and traumatic brain injury. His goal is to help his patients get their lives back using hyperbaric oxygen therapy.
He is the author of The Oxygen Revolution and is considered an International expert and pioneer in the field of Hyperbaric Oxygen Therapy (HBOT). His informative, and comprehensive guide on HBOT has helped countless souls better understand what HBOT is and how it directly affects the body at the genetic level.
This episode on strokes is the sixth in a nine episode series that will be released weekly with Dr. Harch.
Watch the Podcast
In episode 6 of 9, host Edward di Girolamo speaks with world renowned HBOT expert, Dr. Paul G. Harch about strokes. Dr. Harch explains that Hyperbaric Oxygen Therapy is hands-down the most effective therapy to treat the debilitating after-effects of a stroke.
But what exactly happens during a stroke and how can HBOT help?
We have more blood flow happening in the parts of the brain that are working hard to coordinate the movement of muscles, the formation of words, etc. Dr. Harch refers to this blood flow like the RPMs in a motor, the blood flow revs up and increases as we increase our movement & activity. However, having a stroke causes a blockage or lowering of blood flow to the brain, which can cause “electrical silence” – when the cells get to a point at about 60% reduction in blood flow where they no longer have enough oxygen (and blood flow, sugar, and fat) to generate electrical signals. These cells do not die, they live in a state of idling.
Dr. Harch explains there was a strong misunderstanding among the medical community that brain cells were either alive or dead after a stroke or injury. Over the years, HBOT has proven to the medical community that brain cells can just be in an idle/injured state and under the right conditions (like oxygen + pressure) they can be revived to function again.
Dr. Harch speaks in detail of two HBOT success stories of stroke patients getting significantly better even 10 years+ post-stroke —-
- A 60 year old woman who was 14 years post-stroke; paralyzed, drooling, can’t eat, no speech, totally dependent, and spending her days in a Geri Chair. Over the next 16 months they treated her periodically with Hyperbaric Oxygen Therapy and continue to do blood flow brain scans on her before and after the treatments. The deadest area of her brain immediately started to light up with blood flow after just the first treatment. She eventually reacquired her speech, stop drooling, and they were able to get her up moving with assisted ambulation.
- It was early 1990s and a Gentlemen called, Mr. H, who was 12 years post-stroke came into Dr. Harch’s clinic; completely mute with no ability to talk or communicate, unable to move at all; he just laid in bed all day. Eventually his wife had to put him in a nursing home, where he was referred to Hyperbaric Oxygen Therapy for the horrendous bed sore wounds he had developed. They started treatment with HBOT and continued to treat him, even after the bed sores started healing. The medical staff noticed that after about 18 HBOT treatment sessions he was now waving to the doctors and nurses as he was being wheeled through the doors on a stretcher. So they keep treating him with HBOT…… 10 more treatments and he starts talking. By flooding his body with oxygen under the pressure conditions of hyperbarics, for the first time in 12 years his brain started to wake up.
Moving away from topic of stroke, but still focusing on the power of Hyperbarics and success stories, di Girolamo tells Dr. Harch that he once said to Bill Duncan, “From what I understand of Hyperbaric Oxygen, the only thing it can’t do is bring back the dead.” And Bill responded with, “that’s not entirely true”. This opened the door for Dr. Harch to talk about a bizarre and fascinating Hyperbaric Oxygen Therapy success story from the 1980s. A diver was about 80 – 90 feet down in the Mississippi River with an airlift, as part of a mission to salvage a new tugboat that sunk. As the dive team was suctioning silt to loosen it up from the sunken boat, this diver’s helmet came off when he got sucked up against the bar of the dredging device. It took a long time for other divers to find him, and when they do bring him up he’s “dead as dead can be”. Without really knowing exactly why he’s in cardiac arrest, they immediately put him in a hyperbaric chamber in hopes that it would help stabilize him from any decompression sickness. They put an oxygen mask on him and take him to six atmospheres of pressure (clinical chambers go to maximum 3) – that’s 165 feet of pressure! He sparked up and came to life! He had been in cardiac arrest for 25 minutes. He went on to live a healthy life with a bright IQ. Later studies have involved guinea pigs, rats, and swine – some as much as 25 minutes after cardiac arrest and success with resuscitation after Hyperbaric Oxygen Therapy. So, yes there’s scientific proof that HBOT can even bring back the dead.
Dr. Harch stresses at the end of this HBOT Conversation that it’s never too late to get HBOT. Obviously, the sooner the better; but it still works on patients many many years post-stroke. There are approximately 800,000 strokes per year in the United States — it’s a huge number. And unfortunately only an extremely small amount of stroke victims receive Hyperbaric Oxygen Therapy. Dr. Harch classifies HBOT as “hope for the hopeless”.
If you or a loved one has recently experienced a stroke, we encourage you to better understand how Hyperbaric Oxygen Therapy can help wake up a post-stroke brain. We wish you the best as you find hope in HBOT.
Subscribe Now, It’s Free!
Guest
Dr. Paul G. Harch, MD
Dr. Harch initiated and continues to be a private practice that has resulted in the largest case experience in neurological hyperbaric medicine in the world. In this practice, he adapted the concepts of conventional hyperbaric oxygen therapy to wounds in the central nervous system, which spawned the subsequent academic and research practice. Harch HBOT is the best place to receive oxygen therapy treatments, and patients have traveled from more than 50 countries to be treated by Dr. Harch himself.
Harch HBOT – Hyperbaric Oxygen Therapy Clinic
5216 Lapalco Blvd.
Marrero, LA
504-309-4948
hbot@hbot.com
https://hbot.com/
Recent HBOT News
Clinical Trial – Dose and Response of Intrathecal Hydromorphone in Patients Undergoing Cesarean Section at Virginia Commonwealth University Health System
In the United States the incidence of cesarean deliveries have increased over the last
several decades and is currently approximately 30% nationwide. The anesthesia and analgesia
for elective c-sections vary between institutions.
Parturients present a unique challenge for the anesthesiologist as the mother has to care not
only for herself, but also for the newborn postpartum. While intrathecal opioids provide
adequate pain relief, they do so at the cost of bothersome side effects for patients, such as
pruritus and nausea/vomiting.
Intrathecal hydromorphone has started to be explored as a new option for intrathecal
analgesia. A study done by Beatty et al. showed in a retrospective review that 40 mcg of
intrathecal dilaudid was safe and effective as compared to intrathecal morphine for analgesia
after cesarean delivery. Additionally they showed no difference in side effect profiles of
the two medications. Mhyre et al. investigated the use of 100 mcg of intrathecal dilaudid
with hyperbaric bupivacaine in varying dosages for labor analgesia. The results were
inconclusive, but the dosage of hydromorphone was reported to be without adverse effects.
Virginia Commonwealth University Health Systems has successfully instituted the use of
intrathecal morphine with superior analgesia but with undesired side effects, most notably
pruritus. Recent drug shortages of duramorph have prompted investigators to seek alternative
options for post cesarean section analgesia. The investigators are interested in determining
the dose, efficacy, and side effect profile of intrathecal hydromorphone. Although our
institution has never utilized intrathecal hydromorphone for our patient population, it has
been studied at various other institutions where it has been found to be safe and efficacious
with an acceptable side effect profile.
Repeat spinal anesthesia in cesarean section: A comparison between 10 mg and 12 mg doses of intrathecal hyperbaric (0.05%) bupivacaine repeated after failed spinal anesthesia: A prospective, parallel group study.
Abstract: Spinal anesthesia for cesarean section is not a 100% successful technique. At times, despite straightforward insertion and drug administration, intrathecal anesthesia for cesarean section fails to obtain any sensory or motor block. Very few studies and...
Endocan reduces the malign grade of gastric cancer cells by regulating associated protein expression.
Abstract: Endocan, which has been identified to be low expressed in gastric cancer, was found to be positively related to the differentiation level of gastric cancer in vivo and in vitro. In the present study, we aimed to investigate the role of endocan in gastric...
